- Conditions
- Prevention of Zika Infection, Zika-Specific Immune Response
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Zika-Specific Immune Response
Explore clinical trials studying Zika-Specific Immune Response. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Zika-Specific Immune Response trial results
Completed
Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults
NCT02840487
- Conditions
- Prevention of Zika Infection, Zika-Specific Immune Response
- Locations
-
- Hope Clinic - Emory Vaccine Ctr Decatur, Georgia, United States
- University of Maryland Ctr. for Vaccine Development Baltimore, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States